123696澳门论坛

Corporate Governance Announcements and Circulars Presentations Financial Report Investor Inquiry

List of Directors and Their Roles and Functions

Terms of Reference of the Audit Committee

Terms of Reference of the Compensation Committee

Terms of Reference of the Nomination Committee

Procedures for Shareholders to Propose a Person for Election as a Director of the Company

Shareholders' Communication Policy

《Arrangement of Electronic Dissemination of Corporate Communications》_registered shareholders

《Arrangement of Electronic Dissemination of Corporate Communications》_non-registered shareholders

Board of Directors

Mr. Ni Xin

Executive Director

Dr. Han Shuhua

Executive Director

Dr. David Guowei Wang

Non-executive Director

Mr. Yu Tieming

Non-executive Director

Dr. Xu Qing

Independent Non-executive Director

Mr. Chen Wen

Independent Non-executive Director

Ms. Zheng Jingjing

Independent Non-executive Director
Audit Committee

Ms. Zheng Jingjing

Chairman

Mr. Yu Tieming

member

Dr. Xu Qing

Member
Compensation Committee

Dr. Xu Qing

Chairman

Dr. David Guowei Wang

Member

Mr. Chen Wen

member
Nomination Committee

Mr. Ni Xin

Chairman

Dr. Xu Qing

member

Ms. Zheng Jingjing

member

13

2026.05

CHANGE OF JOINT COMPANY SECRETARY

07

2026.05

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2026

04

2026.05

VOLUNTARY ANNOUNCEMENT - LATEST UPDATE ON COOPERATION WITH CANDID THERAPEUTICS

30

2026.04

Next Day Disclosure Return

29

2026.04

Next Day Disclosure Return

28

2026.04

Next Day Disclosure Return

27

2026.04

Next Day Disclosure Return

24

2026.04

Next Day Disclosure Return

23

2026.04

Next Day Disclosure Return

22

2026.04

Next Day Disclosure Return

2026.03

EDDING GENOR 2025 Annual Results

2025.09

1H25 Interim Results Presentation

2025.03

FY2024 Annual Results Presentation

2024.08

1H24 Interim Results Presentation

2024.03

FY2023 Annual Results Presentation

2023.08

1H23 Interim Results Presentation

2022.08

1H22 Interim Results Presentation

2022.03

FY2021 Annual Results Presentation

2021.08

1H21 Interim Results Presentation

2021.03

FY2020 Annual Results Presentation

29

2025.08

2025 Interim Report

30

2025.03

2024 Annual Report

28

2024.08

2024 Interim Report

27

2024.03

2023 Annual Report

30

2023.08

2023 Interim Report

30

2023.03

2022 Annual Report

30

2022.08

2022 Interim Report

30

2022.03

2021 Annual Report

26

2021.08

2021 Interim Report

23

2021.03

2020 Annual Report

Investor Inquiry

Edding Genor Group Holdings Limited

Room 406, Building 1, No. 36 Doukou Road, Hengqin, Zhuhai,China

Room 406, Building 1, No. 36 Doukou Road, Hengqin, Zhuhai,China

IR@eddingpharm.com

IR@eddingpharm.com

红姐新澳论坛-北奥集团